This is the new MLex platform. Existing customers should continue to use the existing MLex platform until migrated.
For any queries, please contact Customer Services or your Account Manager. Dismiss

USTR supports extending deadline to determine widening WTO’s TRIPS Agreement to Covid-19 diagnostics, therapeutics

( December 6, 2022, 22:03 GMT | Official Statement) -- MLex Summary: The Office of the US Trade Representative is supporting the extension of the deadline to decide whether the World Trade Organization’s TRIPS Agreement should cover the production and supply of Covid-19 diagnostics and therapeutics, following the completion of a five-month consultation on the subject. USTR said that it will also ask the US International Trade Commission to begin an investigation of these products, to help inform the discussion around the possibility of extending the TRIPS Agreement to cover Covid-19 diagnostics and therapeutics.Statement follows below:...

Prepare for tomorrow’s regulatory change, today

MLex identifies risk to business wherever it emerges, with specialist reporters across the globe providing exclusive news and deep-dive analysis on the proposals, probes, enforcement actions and rulings that matter to your organization and clients, now and in the longer term.


Know what others in the room don’t, with features including:

  • Daily newsletters for Antitrust, M&A, Trade, Data Privacy & Security, Technology, AI and more
  • Custom alerts on specific filters including geographies, industries, topics and companies to suit your practice needs
  • Predictive analysis from expert journalists across North America, the UK and Europe, Latin America and Asia-Pacific
  • Curated case files bringing together news, analysis and source documents in a single timeline

Experience MLex today with a 14-day free trial.

Start Free Trial

Already a subscriber? Click here to login

Related Sections